“Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.”

Publication Title

NatureMedicine

Authors

Katherine Tuttle, ProvidenceFollow

Document Type

News Article

Publication Date

6-1-2024

Keywords

washington; spokane; pmrc

Area of Special Interest

Kidney & Diabetes

Area of Special Interest

Digestive Health

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Gastroenterology

Specialty/Research Institute

Nephrology